Search Result "L248V"
Basis for Resistance to Imatinib in 16 BCR-ABL Mutants as Determined Using Molecular Dynamics
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 4 Issue: 2 Year: 2009 Page: 164-173
Author(s): Tai-Sung Lee, Steven J. Potts, Maher Albitar
In Silico Identification and Analysis of Drug Resistant Mutants of ABL Tyrosine Kinase Based on Detrimental Missense Mutations
Journal: Current Signal Transduction Therapy
Volume: 6 Issue: 3 Year: 2011 Page: 396-404
Author(s): R. Rajasekaran, C. George Priya Doss, G. Arun Prasad, Rao Sethumadhavan
Molecular Dynamic Studies Unveil Potential Mechanisms of Resistance to Imatinib in BCR-ABL Mutants
Ebook: Topics in Anti-Cancer Research
Volume: 3 Year: 2014
Author(s): Tai-Sung Lee,Steven J. Potts,Maher Albitar
Doi: 10.2174/9781608059089114030011
Chronic Myeloid Leukemia: Existing Therapeutic Options and Strategies to Overcome Drug Resistance
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 19 Issue: 4 Year: 2019 Page: 333-345
Author(s): Vivek Kumar Singh,Mohane Selvaraj Coumar
Second Generation Abl Tyrosine Kinase Inhibitors and Novel Compounds to Eliminate the Bcr-Abl/T315I Clone (Second Edition)
Ebook: Frontiers in Anti-Cancer Drug Discovery
Volume: 1 Year: 2010
Author(s): Shinya Kimura
Doi: 10.2174/978160805161811001010116
Targeting Protein Multiple Conformations: A Structure-Based Strategy for Kinase Drug Design
Journal: Current Topics in Medicinal Chemistry
Volume: 7 Issue: 1 Year: 2007 Page: 1394-1407
Author(s): Liao Jie-Lou Jeffrey, Andrews C. Robert
Second Generation Abl Kinase Inhibitors and Novel Compounds to Eliminate the Bcr-Abl/T315I Clone
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 1 Issue: 3 Year: 2006 Page: 347-355
Author(s): Shinya Kimura
Screening and Activity Evaluation of Novel BCR-ABL/T315I TyrosineKinase Inhibitors
Journal: Current Medicinal Chemistry
Volume: 31 Issue: 20 Year: 2024 Page: 2872-2894
Author(s):
Evaluating Treatment Response of Chronic Myeloid Leukemia: Emerging Science and Technology
Journal: Current Cancer Drug Targets
Volume: 13 Issue: 7 Year: 2013 Page: 779-790
Author(s): Antonia Cagnetta, Anna Garuti, Carlo Marani, Michele Cea, Maurizio Miglino, Ilaria Rocco, Claudia Palermo, Giuseppina Fugazza, Gabriella Cirmena, Nicoletta Colombo, Raffaella Grasso, Alessio Nencioni, Marco Gobbi, Franco Patrone
Second-Generation Tyrosine Kinase Inhibitors as First-Line Treatment Strategy in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients
Journal: Current Cancer Drug Targets
Volume: 12 Issue: 4 Year: 2012 Page: 391-401
Author(s): M. Breccia,G. Alimena